Adenoid Cystic Carcinoma: Clinical and Molecular Features

Head and Neck Pathology

Volumn 7, Issue 1, 2013, Pages 17-22

  Moskaluk, Christopher A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Adenoid cystic carcinoma; MYB; NFIB; Translocation

Indexed keywords

EID: 84874996366     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-013-0426-3     Document Type: Article

References (54)

1. Bonaparte JP, Hart R, Trites J, Taylor MS. Incidence of adenoid cystic carcinoma in nova scotia: 30-year population-based epidemiologic study. J Otolaryngol Head Neck Surg. 2008; 37: 642-8.
2. Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Loftus-Coll BM, Keus RB, Hart AA. Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors. Cancer. 1999; 85: 2255-64.
3. Spiro RH. Salivary neoplasms, overview of a 35 year experience with 2, 807 patients. Head Neck Surg. 1986; 8: 177-84.
4. Isacsson G, Shear M. Intraoral salivary gland tumors: a retrospective study of 201 cases. J Oral Pathol. 1983; 12: 57-62.
5. Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 1985; 146: 51-8.
6. Font RL, Smith SL, Bryan RG. Malignant epithelial tumors of the lacrimal gland: a clinicopathologic study of 21 cases. Arch Ophthalmol. 1998; 116: 613-6.
7. Chen JC, Gnepp DR, Bedrossian CW. Adenoid cystic carcinoma of the salivary glands: an immunohistochemical analysis. Oral Surg, Oral Med Oral Pathol. 1988; 65: 316-26.
8. Prasad AR, Savera AT, Gown AM, Zarbo RJ. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med. 1999; 123: 801-6.
9. Cheng J, Saku T, Okabe H, Furthmayr H. Basement membranes in adenoid cystic carcinoma. An immunohistochemical study. Cancer. 1992; 69: 2631-40.
10. Frierson HF Jr, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J, Saku T, Moskaluk CA, Hampton GM. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol. 2002; 161: 1315-23.
11. Kimura S, Cheng J, Ida H, Hao N, Fujimori Y, Saku T. Perlecan (heparan sulfate proteoglycan) gene expression reflected in the characteristic histological architecture of salivary adenoid cystic carcinoma. Virchows Arch. 2000; 437: 122-8.
12. Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. 1984; 54: 1062-9.
13. Greiner TC, Robinson RA, Maves MD. Adenoid cystic carcinoma clinicopathologic study with flow cytometric analysis. Am J Clin Pathol. 1989; 92: 711-20.
14. Lloyd S, Yu JB, Wilson LD, Decker RH. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol. 2011; 34: 76-81.
15. Rutherford S, Yu Y, Rumpel CA, Frierson HF, Jr., Moskaluk CA: Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma. Cancer Lett. 2006; 236: 309-17.
16. Zarbo RJ. Salivary gland neoplasia: a review for the practicing pathologist. Mod Pathol. 2002; 15: 298-323.
17. Yamamoto Y, Saka T, Makimoto K, Takahashi H. Histological changes during progression of adenoid cystic carcinoma. J Laryngol Otol. 1992; 106: 1016-20.
18. Seethala RR, Hunt JL, Baloch ZW, Livolsi VA, Leon Barnes E. Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. Am J Surg Pathol. 2007; 31: 1683-94.
19. Cheuk W, Chan JKC, Ngan RKC. Dedifferentiation in adenoid cystic carcinoma of salivary gland: an uncommon complication associated with an accelerated clinical course. Am J Surg Pathol. 1999; 23: 465-72.
20. Nagao T, Gaffey TA, Serizawa H, Sugano I, Ishida Y, Yamazaki K, Tokashiki R, Yoshida T, Minato H, Kay PA, Lewis JE. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Mod Pathol. 2003; 16: 1265-72.
21. Fordice J, Kershaw C, el-Naggar A, Goepfert H. Adenoid cystic carcinoma of the head and neck. Predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg. 1999; 125: 149-52.
22. Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hinerman RW, Villaret DB. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 2004; 26: 154-62.
23. Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JM, Schechter NR, Phillips TL, Fu KK, Eisele DW. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys. 2006; 66: 152-9.
24. Barrett AW, Speight PM. Perineural invasion in adenoid cystic carcinoma of the salivary glands: anatomical influences on oncological management. Curr Cancer Ther Rev. 2011; 7: 78-82.
25. Conley J, Dingman DL. Adenoid cystic carcinoma in the head and neck (cylindroma). Arch Otolaryngol. 1974; 100: 81-90.
26. Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg. 1997; 174: 495-8.
27. Nordkvist A, Mark J, Gustavsson H, Bang G, Stenman G. Nonrandom chromosome rearrangements in adenoid cystic carcinoma of the salivary glands. Genes Chromosom Cancer. 1994; 10: 115-21.
28. Jin Y, Mertens F, Limon J, Mandahl N, Wennerberg J, Dictor M, Heim S, Mitelman F. Characteristic karyotypic features in lacrimal and salivary gland carcinomas. Br J Cancer. 1994; 70: 42-7.
29. Jin C, Martins C, Jin Y, Wiegant J, Wennerberg J, Dictor M, Gisselsson D, Strombeck B, Fonseca I, Mitelman F, Tanke HJ, Hoglund M, Mertens F. Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA-FISH. Genes Chromosom Cancer. 2001; 30: 161-7.
30. Higashi K, Jin Y, Johansson M, Heim S, Mandahl N, Biorklund A, Wennerberg J, Hambraeus G, Johansson L, Mitelman F. Rearrangement of 9p13 as the primary chromosomal aberration in adenoid cystic carcinoma of the respiratory tract. Genes Chromosom Cancer. 1991; 3: 21-3.
31. Persson M, Andren Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA. 2009; 106: 18740-4.
32. Mitani Y, Li J, Rao PH, Zhao YJ, Bell D, Lippman SM, Weber RS, Caulin C, El-Naggar AK. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010; 16: 4722-31.
33. Mitani Y, Rao PH, Futreal PA, Roberts DB, Stephens PJ, Zhao YJ, Zhang L, Mitani M, Weber RS, Lippman SM, Caulin C, El-Naggar AK. Novel chromosomal rearrangements and break points at the t(6; 9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res. 2011; 17: 7003-14.
34. West RB, Kong C, Clarke N, Gilks T, Lipsick JS, Cao H, Kwok S, Montgomery KD, Varma S, Le QT. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am J Surg Pathol. 2011; 35: 92-9.
35. Moskaluk CA, Baras AS, Mancuso SA, Fan H, Davidson RJ, Dirks DC, Golden WL, Frierson HF Jr. Development and characterization of xenograft model systems for adenoid cystic carcinoma. Lab Invest. 2011; 91: 1480-90.
36. Brill LB, 2nd, Kanner WA, Fehr A, Andren Y, Moskaluk CA, Loning T, Stenman G, Frierson HF, Jr.: Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol. 2011; 24: 1169-76.
37. Bell D, Roberts D, Karpowicz M, Hanna EY, Weber RS, El-Naggar AK. Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma. Cancer Biol Ther. 2011; 12: 569-73.
38. Bernheim A, Toujani S, Saulnier P, Robert T, Casiraghi O, Validire P, Temam S, Menard P, Dessen P, Fouret P. High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma. Lab Invest. 2008; 88: 464-73.
39. Rao PH, Roberts D, Zhao YJ, Bell D, Harris CP, Weber RS, El-Naggar AK. Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res: Off J Am Assoc Cancer Res. 2008; 14: 5181-7.
40. Vekony H, Ylstra B, Wilting SM, Meijer GA, van de Wiel MA, Leemans CR, van der Waal I, Bloemena E. DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma. Clin Cancer Res. 2007; 13: 3133-9.
41. El-Rifai W, Rutherford S, Knuutila S, Frierson HF Jr, Moskaluk CA. Novel DNA copy number losses in chromosome 12q12-q13 in adenoid cystic carcinoma. Neoplasia. 2001; 3: 173-8.
42. Yu Y, Baras AS, Shirasuna K, Frierson HF Jr, Moskaluk CA. Concurrent loss of heterozygosity and copy number analysis in adenoid cystic carcinoma by SNP genotyping arrays. Lab Invest. 2007; 87: 430-9.
43. Freier K, Flechtenmacher C, Walch A, Ohl S, Devens F, Burke B, Hassfeld S, Lichter P, Joos S, Hofele C. Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis. Cancer Genet Cytogenet. 2005; 159: 89-95.
44. Moskaluk CA, Frierson HF, Jr., El-Naggar AK, Futreal PA: C-kit gene mutations in adenoid cysstic carcinoma are rare, Mod Pathol 2010, 23: 905-906; Author reply 906-907.
45. Aubry MC, Heinrich MC, Molina J, Lewis JE, Yang P, Cassivi SD, Corless CL. Primary adenoid cystic carcinoma of the lung: absence of KIT mutations. Cancer. 2007; 110: 2507-10.
46. Holst VA, Marshall CE, Moskaluk CA, Frierson HF Jr. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol. 1999; 12: 956-60.
47. Jeng YM, Lin CY, Hsu HC. Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett. 2000; 154: 107-11.
48. Lin CH, Yen RF, Jeng YM, Tzen CY, Hsu C, Hong RL. Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate. Head Neck. 2005; 27: 1022-7.
49. Sorensen KB, Godballe C, de Stricker K, Krogdahl A. Parotid carcinoma: expression of kit protein and epidermal growth factor receptor. J Oral Pathol Med. 2006; 35: 286-91.
50. Vila L, Liu H, Al-Quran SZ, Coco DP, Dong HJ, Liu C: Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland. Mod Pathol. 2009; 22: 1296-302.
51. Saka T, Yamamoto Y, Takahashi H. Comparative cytofluorometric DNA analysis of pleomorphic adenoma and adenoid cystic carcinoma of the salivary glands. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991; 61: 255-61.
52. Franzen G, Nordgard S, Boysen M, Larsen PL, Halvorsen TB, Clausen OP. DNA content in adenoid cystic carcinomas. Head Neck. 1995; 17: 49-55.
53. Seethala RR, Cieply K, Barnes EL, Dacic S. Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation. Arch Pathol Lab Med. 2011; 135: 123-30.
54. Londono-Vallejo JA. Telomere length heterogeneity and chromosome instability. Cancer Lett. 2004; 212: 135-44.